Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 10, 2010, Pages 870-876

  Hoffmeister, Michael ^a   Schmitz, Stephanie ^a   Karmrodt, Elisabeth ^a   Stegmaier, Christa ^b   Haug, Ulrike ^a   Arndt, Volker ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Saarland Cancer Registry   (Germany)

Author keywords

Attributable Risk; Bootstrap; Gender; Relative Risk

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; INTESTINE POLYP; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX DIFFERENCE; SMOKING;

ADENOMA; AGED; AGED, 80 AND OVER; COLONIC POLYPS; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FAMILY HEALTH; FEMALE; GERMANY; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 77957108842     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.07.004     Document Type: Article

References (43)

1. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008, 58:130-160.
2. Schmiegel W., Reinacher-Schick A., Arnold D., et al. [Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol 2008, 46:799-840.
3. Schmiegel W., Pox C., Adler G., et al. [S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol 2004, 42:1129-1177.
4. Brenner H., Hoffmeister M., Haug U. Family history and age at initiation of colorectal cancer screening. Am J Gastroenterol 2008, 103:2326-2331.
5. Lieberman D. Race, gender, and colorectal cancer screening. Am J Gastroenterol 2005, 100:2756-2758.
6. Botteri E., Iodice S., Raimondi S., et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008, 134:388-395.
7. Shrubsole M.J., Wu H., Ness R.M., et al. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 2008, 167:1050-1058.
8. Ji B.T., Weissfeld J.L., Chow W.H., et al. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2006, 15:897-901.
9. Lieberman D.A., Prindiville S., Weiss D.G., et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003, 290:2959-2967.
10. Giovannucci E., Colditz G.A., Stampfer M.J., et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 1994, 86:192-199.
11. Giovannucci E., Rimm E.B., Stampfer M.J., et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994, 86:183-191.
12. Verla-Tebit E., Lilla C., Hoffmeister M., et al. Cigarette smoking and colorectal cancer risk in Germany: a population-based case-control study. Int J Cancer 2006, 119:630-635.
13. Botteri E., Iodice S., Bagnardi V., et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008, 300:2765-2778.
14. Nguyen S.P., Bent S., Chen Y.H., et al. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009, 7:676-681. e1-3.
15. Brenner H., Haug U., Arndt V., et al. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 2010, 138:870-876.
16. Spiegelman D., Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005, 162:199-200.
17. Bruzzi P., Green S.B., Byar D.P., et al. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985, 122:904-914.
18. Miettinen O.S. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974, 99:325-332.
19. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001, 10:195-216.
20. Miller DP. Bootstrap 101: obtain robust confidence intervals for any statistic. Proceedings of the 29th annual SAS users group international conference. Vol 29. Montréal, Canada: SAS Institute Inc, 2004.
21. Johns L.E., Houlston R.S. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001, 96:2992-3003.
22. Anderson J.C., Attam R., Alpern Z., et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol 2003, 98:2777-2783.
23. Brenner H., Hoffmeister M., Arndt V., et al. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 2007, 96:828-831.
24. Brenner H., Hoffmeister M., Stegmaier C., et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 2007, 56:1585-1589.
25. Schoenfeld P., Cash B., Flood A., et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005, 352:2061-2068.
26. Regula J., Rupinski M., Kraszewska E., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006, 355:1863-1872.
27. Brenner H., Chang-Claude J., Seiler C.M., et al. Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study. Cancer Epidemiol Biomarkers Prev 2007, 16:494-499.
28. Baxter N.N., Goldwasser M.A., Paszat L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009, 150:1-8.
29. Brenner H., Hoffmeister M., Arndt V., et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010, 102:89-95.
30. Brenner H., Hoffmeister M., Brenner G., et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 2009, 45:2027-2033.
31. Lansdorp-Vogelaar I., van Ballegooijen M., Zauber A.G., et al. Individualizing colonoscopy screening by sex and race. Gastrointest Endosc 2009, 70:96-108. 108 e1-24.
32. Rockhill B., Newman B., Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998, 88:15-19.
33. Gefeller O. The concept of attributable risk in epidemiology: yesterday, today and tomorrow. Stat Methods Med Res 2001, 10:157-158.
34. Ramsch C., Pfahlberg A.B., Gefeller O. Point and interval estimation of partial attributable risks from case-control data using the R-package "pARccs". Comput Methods Programs Biomed 2009, 94:88-95.
35. Winawer S.J. Natural history of colorectal cancer. Am J Med 1999, 106:3S-6S. discussion 50S-51S.
36. Bond J.H. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps-Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000, 95:3053-3063.
37. Hoffmeister M., Chang-Claude J., Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol 2007, 166:130-136.
38. Murff H.J., Spigel D.R., Syngal S. Does this patient have a family history of cancer?. An evidence-based analysis of the accuracy of family cancer history. JAMA 2004, 292:1480-1489.
39. Patrick D.L., Cheadle A., Thompson D.C., et al. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994, 84:1086-1093.
40. Ahmed S., Leslie A., Thaha M.A., et al. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population. Br J Surg 2005, 92:478-481.
41. Dube C., Rostom A., Lewin G., et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007, 146:365-375.
42. Rostom A., Dube C., Lewin G., et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007, 146:376-389.
43. Daly L.E. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 1998, 147:783-790.